ZMYND11 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.713000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.250600E-01
Normal-vs-Stage2
2.811000E-01
Normal-vs-Stage3
6.638500E-03
Normal-vs-Stage4
7.732400E-01
Stage1-vs-Stage2
3.554600E-01
Stage1-vs-Stage3
5.888200E-02
Stage1-vs-Stage4
5.262000E-01
Stage2-vs-Stage3
1.096380E-01
Stage2-vs-Stage4
8.706400E-02
Stage3-vs-Stage4
8.687500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.760600E-01
Normal-vs-AfricanAmerican
8.371400E-01
Normal-vs-Asian
1.332430E-01
Caucasian-vs-AfricanAmerican
3.456200E-01
Caucasian-vs-Asian
1.025640E-01
AfricanAmerican-vs-Asian
9.478000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.484600E-01
Normal-vs-Female
4.121400E-01
Male-vs-Female
7.794000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.967550E-01
Normal-vs-Age(41-60Yrs)
6.817800E-01
Normal-vs-Age(61-80Yrs)
2.836400E-01
Normal-vs-Age(81-100Yrs)
6.265700E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.791600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.921400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.734000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.529900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.524000E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.318400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.916810E-01
Normal-vs-Daily Drinker
5.847500E-02
Normal-vs-Weekly Drinker
2.461800E-01
Normal-vs-Occasional Drinker
6.645800E-01
Normal-vs-Social Drinker
5.632800E-01
Non Drinker-vs-Daily Drinker
4.873800E-01
Non Drinker-vs-Weekly Drinker
9.912400E-01
Non Drinker-vs-Occasional Drinker
2.250000E-01
Non Drinker-vs-Social Drinker
4.472400E-01
Daily Drinker-vs-Weekly Drinker
5.760600E-01
Daily Drinker-vs-Occasional Drinker
1.101830E-01
Daily Drinker-vs-Social Drinker
2.678200E-01
Weekly Drinker-vs-Occasional Drinker
3.456000E-01
Weekly Drinker-vs-Social Drinker
5.507800E-01
Occasional Drinker-vs-Social Drinker
7.715000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.298400E-02
Normal-vs-Grade 2
1.461570E-02
Normal-vs-Grade 3
2.884200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.446200E-01
Grade 1-vs-Grade 3
5.486800E-01
Grade 1-vs-Grade 4
6.298400E-02
Grade 2-vs-Grade 3
6.210800E-01
Grade 2-vs-Grade 4
1.461570E-02
Grade 3-vs-Grade 4
2.884200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.518200E-01
Normal-vs-NonDiabetic
2.818800E-01
Diabetic-vs-NonDiabetic
9.566400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.420600E-01
Normal-vs-NoPancreatitis
3.081200E-01
Pancreatitis-vs-NoPancreatitis
4.507000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.937800E-01
Normal-vs-N1
3.065200E-01
N0-vs-N1
5.352200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.099600E-01
Normal-vs-TP53-NonMutant
8.425600E-01
TP53-Mutant-vs-TP53-NonMutant
2.955800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
